drugset / Trial / NCT03127670

Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion

NCT03127670 ↗

NaSingle-groupOpen-labelTreatment

Summary

Solanum melongena is a common vegetable contains phytochemicals which prevent, reduce or delay the oxidation of DNA and alter the cellular signal transduction pathways controlling cell proliferation and apoptosis of human cancer. The skin of Solanum melongena peel contains nasunin an anthocyanins and chlorogenic acid which have anti-inflammatory, antioxidant, antimutagenic and antiangiogenic properties. Extract of Solanum melongena is used in actinic keratosis and Squamous cell carcinoma of the skin. This study will determine any change in arsenical skin lesion after administrating Solanum melongena extract cream.

Timeline

Start
2016-11-14
Primary completion
2017-12-31
Completion
2017-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Solanum melongena peel extract Unknown 0.05 % Topical

Indications